pubmed-article:17135217 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17135217 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:17135217 | lifeskim:mentions | umls-concept:C0025815 | lld:lifeskim |
pubmed-article:17135217 | lifeskim:mentions | umls-concept:C0024143 | lld:lifeskim |
pubmed-article:17135217 | lifeskim:mentions | umls-concept:C0004358 | lld:lifeskim |
pubmed-article:17135217 | lifeskim:mentions | umls-concept:C0004482 | lld:lifeskim |
pubmed-article:17135217 | lifeskim:mentions | umls-concept:C0010583 | lld:lifeskim |
pubmed-article:17135217 | lifeskim:mentions | umls-concept:C0391850 | lld:lifeskim |
pubmed-article:17135217 | lifeskim:mentions | umls-concept:C0334094 | lld:lifeskim |
pubmed-article:17135217 | lifeskim:mentions | umls-concept:C0033522 | lld:lifeskim |
pubmed-article:17135217 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
pubmed-article:17135217 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:17135217 | pubmed:dateCreated | 2007-4-30 | lld:pubmed |
pubmed-article:17135217 | pubmed:abstractText | To study the prevalence and course of anti-chromatin (anti-nucleosome, anti-double-stranded (ds) DNA and anti-histone) and anti-C1q autoantibodies in patients with proliferative lupus nephritis (LN), treated in a randomised controlled trial with either cyclophosphamide or azathioprine plus methylprednisolone. | lld:pubmed |
pubmed-article:17135217 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:language | eng | lld:pubmed |
pubmed-article:17135217 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17135217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17135217 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17135217 | pubmed:month | May | lld:pubmed |
pubmed-article:17135217 | pubmed:issn | 0003-4967 | lld:pubmed |
pubmed-article:17135217 | pubmed:author | pubmed-author:DahaMohamed... | lld:pubmed |
pubmed-article:17135217 | pubmed:author | pubmed-author:RoosAnjaA | lld:pubmed |
pubmed-article:17135217 | pubmed:author | pubmed-author:DerksenRonald... | lld:pubmed |
pubmed-article:17135217 | pubmed:author | pubmed-author:BerdenJo H... | lld:pubmed |
pubmed-article:17135217 | pubmed:author | pubmed-author:Grootscholten... | lld:pubmed |
pubmed-article:17135217 | pubmed:author | pubmed-author:van der... | lld:pubmed |
pubmed-article:17135217 | pubmed:author | pubmed-author:DiekerJürgen... | lld:pubmed |
pubmed-article:17135217 | pubmed:author | pubmed-author:McGrathFabian... | lld:pubmed |
pubmed-article:17135217 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17135217 | pubmed:volume | 66 | lld:pubmed |
pubmed-article:17135217 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17135217 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17135217 | pubmed:pagination | 693-6 | lld:pubmed |
pubmed-article:17135217 | pubmed:dateRevised | 2010-9-14 | lld:pubmed |
pubmed-article:17135217 | pubmed:meshHeading | pubmed-meshheading:17135217... | lld:pubmed |
pubmed-article:17135217 | pubmed:meshHeading | pubmed-meshheading:17135217... | lld:pubmed |
pubmed-article:17135217 | pubmed:meshHeading | pubmed-meshheading:17135217... | lld:pubmed |
pubmed-article:17135217 | pubmed:meshHeading | pubmed-meshheading:17135217... | lld:pubmed |
pubmed-article:17135217 | pubmed:meshHeading | pubmed-meshheading:17135217... | lld:pubmed |
pubmed-article:17135217 | pubmed:meshHeading | pubmed-meshheading:17135217... | lld:pubmed |
pubmed-article:17135217 | pubmed:meshHeading | pubmed-meshheading:17135217... | lld:pubmed |
pubmed-article:17135217 | pubmed:meshHeading | pubmed-meshheading:17135217... | lld:pubmed |
pubmed-article:17135217 | pubmed:meshHeading | pubmed-meshheading:17135217... | lld:pubmed |
pubmed-article:17135217 | pubmed:meshHeading | pubmed-meshheading:17135217... | lld:pubmed |
pubmed-article:17135217 | pubmed:meshHeading | pubmed-meshheading:17135217... | lld:pubmed |
pubmed-article:17135217 | pubmed:meshHeading | pubmed-meshheading:17135217... | lld:pubmed |
pubmed-article:17135217 | pubmed:meshHeading | pubmed-meshheading:17135217... | lld:pubmed |
pubmed-article:17135217 | pubmed:meshHeading | pubmed-meshheading:17135217... | lld:pubmed |
pubmed-article:17135217 | pubmed:meshHeading | pubmed-meshheading:17135217... | lld:pubmed |
pubmed-article:17135217 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17135217 | pubmed:articleTitle | A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone. | lld:pubmed |
pubmed-article:17135217 | pubmed:affiliation | Division of Nephrology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. | lld:pubmed |
pubmed-article:17135217 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17135217 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:17135217 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17135217 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17135217 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17135217 | lld:pubmed |